Progeniture (procreation) – in our company name, defines vividly what we stand for. Our future depends on our next generation. Our offspring’s, our children. Every individual has the right to a healthy, lively child. We at Progeniture Laboratories Ltd, provides essential medicine to fulfil these expectations.
Life Essential Medicine. Supporting Families Worldwide.
Progeniture Laboratories Ltd. is a young and dynamic pharmaceutical company, focussing of bringing innovative and progressive medicine in the field of infertility treatment.
With more of 60 years of combined experience and collaboration within the field of infertility drugs, Progeniture Laboratories Ltd, incorporates modern methodologies, adherence programmes, innovative drug delivery technologies to enhance patient centric healthcare, and improve patient experience in the treatment of infertility.
The reproductive system is subjected to the environment with its cultural and socio-economic factors. Etiology of infertility varies from region to region and from one population to another and even from one locality to another within the same population. For a large part, involuntary infertility is related to conditions that are preventable in principle such as sexually transmitted diseases, infections and parasitic diseases, health care practices leading to iatrogenic pathology, exposure to toxic substances either in the diet or environment and complications suffered during post partum or post abortion period, particularly in case of an unsafely induced abortion.
Infertility is a worldwide problem affecting 8-12 percent couple (50-80 million) during their reproductive lives.
According to the Indian Society of Assisted Reproduction, infertility currently affects about 10 – 14 % of the Indian population, with higher rates in urban areas where one out of six couples is impacted. Nearly 27.5 million couples actively trying to conceive suffer from infertility in India.
Childlessness in India is estimated around 2.5 percent. It is around 5.5 percent for 30-49 age group and 5.2 percent for 45-49 age group. In absolute terms it is around 4.9 million and if secondary infertility is also added to it than the total number of infertile couples is around 17.9 million. Infertility has been relatively neglected as both a health problem and a subject for social science research in South Asia, as in the developing world more generally. The general thrust of both programmes and research has been on the correlates of high fertility and its regulation rather than understanding the context of infertility.
Childlessness has serious demographic, social and health implications. The conflux of personal, interpersonal, social, and religious expectations may bring a sense of failure, loss, and exclusion to those who are infertile. Relationships between couples can become very strained when children are not forthcoming. One partner may seek to blame the other as being defective or unwilling. Childless couples are sometimes excluded from taking leading roles in important family functions and events such as birthdays, christenings, confirmations, bar mitzvahs and weddings. Moreover, many religions assign important ceremonial tasks to the couple’s children. Many societies are organized in such a way that children are necessary for care and maintenance of older parents. Even in developed countries with social support systems, children and family are expected to provide much of the care for the elderly. Living as an involuntarily childless woman is challenging for feminity and the female role. Norms may be difficult for those who prefer to live according to them, but they are even more difficult for those who have no choice. Childlessness is of particular concern because of the global extent of the problem and the social stigma attached to it.
